Mike Baldzicki | Vice President Specialty Pharmacy Biopharma Access & Growth
Walgreens

Michael J. Baldzicki Vice President, BioPharma & Access
Walgreens Enterprise Specialty Pharmacy Michael J. Baldzicki is Vice President, BioPharma & Access for Walgreens Enterprise Specialty Pharmacy, where he leads strategies focused on expanding pharmaceutical manufacturer partnerships, limited-distribution drug access, specialty commercialization, and emerging cell and gene therapy opportunities. His work connects manufacturers, payers, providers, health systems, and patients through integrated market-access, channel, distribution, and patient-support solutions. With more than 27 years of healthcare leadership experience, Michael has built a career across specialty pharmacy, home infusion, biopharmaceuticals, healthcare services, technology, and strategic business development. He has led national product launches, developed multi-channel distribution partnerships, and designed innovative commercialization and access models supporting specialty, rare disease, oncology, infusion, and cell and gene therapies. Throughout his career, Michael has held leadership roles and worked with organizations including Bristol Myers Squibb, Baxter, Novo Nordisk, AmerisourceBergen, Diplomat Pharmacy, and Asembia. His experience spans market access, business development, corporate strategy, manufacturer services, payer engagement, channel optimization, mergers and acquisitions, and capital markets. Michael is a nationally recognized industry speaker and thought leader who frequently presents on specialty pharmacy economics, limited-distribution networks, rare and ultra-orphan therapies, cell and gene therapy commercialization, digital health, patient access, value-based care, and specialty pharmacy innovation. He has presented at major industry forums hosted by NASP, AMCP, Asembia, PBMI, NORD, Informa, HCAA, SIIA, NCPDP, and the National Alliance of Healthcare Purchaser Coalitions. He has also contributed to numerous industry boards, advisory councils, publications, podcasts, webinars, and research initiatives. Michael is known for translating complex market dynamics into practical growth strategies that improve patient access, strengthen partnerships, and create sustainable enterprise value.